Advertisement

Computational study of binding of epothilone A to β-tubulin.

02:37 EDT 20th June 2013 | BioPortfolio

Summary of "Computational study of binding of epothilone A to β-tubulin."

Understanding the interactions of epothilones with β-tubulin is crucial for computer aided rational design of macrocyclic drugs based on epothilones and epothilone derivatives. Despite numerous structure-activity relationship investigations we still lack substantial knowledge about the binding mode of epothilones and their derivatives to β-tubulin. In this work, we reevaluated the electron crystallography structure of epothilone A/β-tubulin complex (PDB entry 1TVK) and proposed an alternative binding mode of epothilone A to β-tubulin that explains more experimental facts.

Affiliation

Laboratory of Theory of Biopolymers, Faculty of Chemistry, University of Warsaw, Warsaw, Poland.

Journal Details

This article was published in the following journal.

Name: Acta biochimica Polonica
ISSN: 1734-154X
Pages:

Links

Medical and Biotech [MESH] Definitions

Tubulin Modulators

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES.

Microtubules

Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.

N-methylscopolamine

A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.

Neurocalcin

A neuronal calcium sensor protein that is expressed as several isoforms and can interact with ACTIN; TUBULIN; and CLATHRIN.

Antimitotic Agents

Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS.

PubMed Articles [ 10746 Associated PubMed Articles listed on BioPortfolio]

C6-c8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.

A series of conformationally restrained epothilone analogues with a short bridge between the methyl groups at C6 and C8 was designed to mimic the binding pose assigned to our recently reported EpoA-mi...

New epothilone congeners from Sorangium cellulosum strain So0157-2.

As a continuous work to find more epothilone congeners produced by the epothilones A and B producing Sorangium cellulosum strain So0157-2 in the large-scale fermentation (5000 L), we reinvestigated...

Radiosensitizing effect of epothilone B on human epithelial cancer cells.

BACKGROUND: A combined modality treatment employing radiation and chemotherapy plays a central role in the management of solid tumors. In our study, we examined the cytotoxic and...

Quantum-Chemical Study on the Bioactive Conformation of Epothilones.

Herein, I report a DFT study on the bioactive conformation of epothilone A based on the analysis of 92 stable conformations of free and bound epothilone to a reduced model of tubulin receptor. The equ...

Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin.

Tubulin is an attractive and established target for anticancer therapy. To date, the only method to determine the binding of inhibitor to tubulin has been competitive radioligand binding assays. We de...

Clinical Trials [ 179 Associated Clinical Trials listed on BioPortfolio]

Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer

The purpose of this study is to determine the maximally tolerated dose and the dose limiting toxicity of this antimitotic, tubulin binding investigational drug for those patients who have...

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

RATIONALE: Drugs used in chemotherapy, such as epothilone B, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPO...

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

RATIONALE: Drugs used in chemotherapy such as epothilone D work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying h...

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

RATIONALE: Drugs used in chemotherapy, such as epothilone ZK-219477, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing...

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

The purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) in patients with metastatic breast cancer helps to decrease or stop tumor growth.

Search BioPortfolio: